Allergan, Inc. is a leading maker of eye care, skin care, and aesthetic products, including best-selling pharmaceutical Botox. Originally used to treat muscle spasms (as well as eye spasms and misalignment), Botox has found another, more popular application in diminishing facial wrinkles. Allergan’s eye care products include medications for glaucoma, allergic conjunctivitis, and chronic dry eye. Skin care products include treatments for acne, wrinkles, and psoriasis. Allergan also sells implants used in breast augmentation and weight-loss surgery. Its products are sold in 100 countries via direct sales and distributors.”[1]
Criticism
Worker Rights
- Chairman and CEO David E. I. Pyott had total pay of $11,911,106 in 2008 according to Forbes.[2]
Political Influence
- In the 2008 U.S. election, Allergan gave $130,000 to Federal candidates through its political action committee – 42% to Democrats and 58% to Republicans.[3]
- In 2006, it gave $91,250 – 15% to Democrats and 85% to Republicans.
- In 2008, it spent $1,550,000 for lobbying.[4]
Brands and Subsidiaries
- RESTASIS ophthalmic emulsion; LUMIGAN ophthalmic solution; OPTIVE Lubricant Eye Drops; REFRESH Brand line of artificial tears; BOTOX (onabotulinumtoxinA); LAP-BAND; Natrelle; JUVEDERM; ACZONE; AVAGE; AZELEX; TAZORAC; SANCTURA XR[5][6]
- Inamed Pty Ltd, Australia; Collagen Aesthetics Benelux S.A., Belgium; Inamed do Brazil Ltda, Brazil; Collagen Aesthetics France SARL; S.C.I. Focus, France; Pharm-Allergan GmbH, Germany; McGhan Limited, Ireland; BioEnterics Limited, Ireland; Chamfield Limited, Ireland; Seabreeze Silicone Limited, Ireland; Endoart Singapore Pte. Ltd; CUI Corporation; Herbert Laboratories; Inamed Development Company; Oculex Pharmaceuticals, Inc; Silicone Engineering, Inc; Flowmatrix Corporation; TotalSkinCare.com Corporation[7]